UTMB patients with COPD are eligible to participate in the free support group that meets monthly in Galveston.

UTMB Health Bariatrics patient Felicity Cunningham joined Houston Moms to share her journey of losing half her body weight after having bariatrics surgery at UTMB Health.

Health Care Unmasked—a monthly video interview series that features health and life science experts from UTMB dissecting topics with series host and owner of i45Now, TJ Aulds—will now be known as UTMB Health Insights.

The University of Texas Medical Branch, patients in our local communities and the broader Houston-Galveston region could eventually have access to the most advanced neurological medical technologies thanks to a collaboration between UTMB and the Wyss Center, a world leading neuroengineering and neurotechnology research non-profit.

UTMB Licensed Clinical Psychologist Dr. Kimberly Gushanas shares insights on how time outside can impact one's existential, spiritual and emotional wellbeing. The researcher also shares tips for those looking to increase their exposure to nature.

U.S. News & World Report named the University of Texas Medical Branch a 2025 High Performing Hospital for Maternity Care. The award is the highest a hospital can earn as part of U.S. News’ Best Hospitals for Maternity Care annual study.

The University of Texas Medical Branch Department of Pathology is the first academic healthcare center in Texas to add an artificial intelligence-based-tool to its routine workflow for the diagnosis of prostate cancer.

University of Texas Medical Branch's Yolanda Leyva has been named one of 10 NICU nurses selected as a finalist in the second annual Nominate a NICU Nurse program.

A new method of assessing patient blood by running it through a miniaturized device that mimics narrowed arteries could help doctors better understand a patient’s risk factors for developing blood clots in the arteries according to a study published in Nature by researchers at the University of Texas Medical Branch.

A new study published in the American Journal of Medicine has found that medications commonly prescribed for erectile dysfunction—tadalafil (Cialis) and sildenafil (Viagra)—are associated with significant reductions in deaths, cardiovascular disease and dementia in middle-aged men. The study was conducted by researchers at the University of Texas Medical Branch and assessed outcomes over a three-year follow-up period.